Hana Pharm Co., Ltd. (KRX:293480)

Hana Pharm Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2017	FY 2016
Period Ending	Dec 31, 2017	Dec 31, 2016
Net Income	24,305	17,431
Depreciation & Amortization	3,522	3,678
Loss (Gain) From Sale of Assets	-234.01	19.1
Asset Writedown & Restructuring Costs	-	108.48
Provision & Write-off of Bad Debts	-389.2	201.78
Other Operating Activities	1,832	-969.09
Change in Accounts Receivable	-2,737	-9,190
Change in Inventory	-1,243	-3,641
Change in Accounts Payable	444.72	574.97
Change in Other Net Operating Assets	-119.39	4,251
Operating Cash Flow	25,380	12,464
Operating Cash Flow Growth	103.63%	-
Capital Expenditures	-10,193	-8,310
Sale of Property, Plant & Equipment	102.56	33.7
Cash Acquisitions	360	-
Sale (Purchase) of Intangibles	-1,228	-51.91
Investment in Securities	-1,842	962.41
Other Investing Activities	-17.23	-475.77
Investing Cash Flow	-12,818	-9,310
Short-Term Debt Issued	1,006	3,398
Long-Term Debt Issued	500	4,000
Total Debt Issued	1,506	7,398
Short-Term Debt Repaid	-1,019	-5,214
Long-Term Debt Repaid	-2,367	-6,398
Total Debt Repaid	-3,386	-11,612
Net Debt Issued (Repaid)	-1,880	-4,215
Issuance of Common Stock	1,892	1,862
Dividends Paid	-1,023	-
Other Financing Activities	0.81	19.24
Financing Cash Flow	-1,011	-2,334
Miscellaneous Cash Flow Adjustments	0	-
Net Cash Flow	11,551	820.74
Free Cash Flow	15,187	4,154
Free Cash Flow Growth	265.64%	-
Free Cash Flow Margin	10.90%	3.34%
Free Cash Flow Per Share	1401.56	535.67
Cash Interest Paid	1,083	1,426
Cash Income Tax Paid	5,814	6,531
Levered Free Cash Flow	7,304	-
Unlevered Free Cash Flow	7,957	-
Change in Net Working Capital	4,025	-

Source: S&P Capital IQ. Standard template. Financial Sources.